 |
PDBsum entry 2pog
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Lipid binding protein
|
PDB id
|
|
|
|
2pog
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lipid binding protein
|
 |
|
Title:
|
 |
Benzopyrans as selective estrogen receptor b agonists (serbas). Part 2: structure activity relationship studies on the benzopyran scaffold.
|
|
Structure:
|
 |
Estrogen receptor. Chain: a, b. Fragment: ligand binding domain (residues 304-551). Synonym: er, estradiol receptor, er-alpha. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: esr1. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.84Å
|
R-factor:
|
0.235
|
R-free:
|
0.252
|
|
|
Authors:
|
 |
T.I.Richardson,B.H.Norman,C.W.Lugar,S.A.Jones,Y.Wang,J.D.Durbin, V.Krishnan,J.A.Dodge
|
|
Key ref:
|
 |
T.I.Richardson
et al.
(2007).
Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Bioorg Med Chem Lett,
17,
3570-3574.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-Apr-07
|
Release date:
|
11-Sep-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
17:3570-3574
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
|
|
T.I.Richardson,
B.H.Norman,
C.W.Lugar,
S.A.Jones,
Y.Wang,
J.D.Durbin,
V.Krishnan,
J.A.Dodge.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Benzopyrans are selective estrogen receptor (ER) beta agonists (SERBAs), which
bind the ER subtypes alpha and beta in opposite orientations. Here we describe
structure-activity relationship studies that led to the discovery of bezopyran
5b. X-ray crystal structures of 5b and a non-selective analog 5c in ERalpha help
explain the observed selectivity of the benzopyran platform.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Minutolo,
M.Macchia,
B.S.Katzenellenbogen,
and
J.A.Katzenellenbogen
(2011).
Estrogen receptor β ligands: recent advances and biomedical applications.
|
| |
Med Res Rev,
31,
364-442.
|
 |
|
|
|
|
 |
J.P.Salisbury,
and
J.C.Williams
(2009).
Docking study of triphenylphosphonium cations as estrogen receptor alpha modulators.
|
| |
Bioinformation,
3,
303-307.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|